UCART20x22

· Cellectis S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UCART20x22, covering 2025-08-24 to 2025-08-24. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]